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Brucella abortus is a Gram-negative, facultative intracellular bacterium that causes bru-
cellosis, a worldwide zoonotic disease leading to undulant fever in humans and abortion 
in cattle. The immune response against this bacterium relies on the recognition of micro-
bial pathogen-associated molecular patterns, such as lipoproteins, lipopolysaccharides, 
and DNA; however, the immunostimulatory potential of B. abortus RNA remains to be 
elucidated. Here, we show that dendritic cells (DCs) produce significant amounts of 
IL-12, IL-6, and IP-10/CXCL10, when stimulated with purified B. abortus RNA. IL-12 
secretion by DCs stimulated with RNA depends on TLR7 while IL-6 depends on TLR7 
and partially on TLR3. Further, only TLR7 plays a role in IL-12 production induced by 
B. abortus infection. Moreover, cytokine production in DCs infected with B. abortus 
or stimulated with bacterial RNA was reduced upon pretreatment with MAPK/NF-κB 
inhibitors. By confocal microscopy, we demonstrated that TLR7 is colocalized with 
B. abortus in LAMP-1+ Brucella-containing vacuoles. Additionally, type I IFN expression 
and IP-10/CXCL10 secretion in DCs stimulated with bacterial RNA were dependent on 
TLR3 and TLR7. Our results suggest that TLR3 and TLR7 are not required to control 
Brucella infection in vivo, but they play an important role on sensing B. abortus RNA 
in vitro.
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inTrODUcTiOn
The innate immunity is important to the initial recognition of pathogens, the development of a 
neutralizing response, and mobilization of the adaptive immunity (1). This defense relies on a limited 
set of evolutionary conserved pattern recognition receptors (PRRs) that recognize specific pathogen-
associated molecular patterns (PAMPs) commonly present in microbes but not in mammals. Upon 
detection of PAMPs, some PRRs trigger an inflammatory response leading to the efficient destruc-
tion of the invading pathogens (2). Among these PRRs, the toll-like receptors (TLRs) family has 
gained more attention (1, 3).
Toll-like receptors are a well-conserved family of proteins, characterized by an extracellular 
leucine-rich repeat domain and an intracellular toll/IL-1 receptor-like domain (4). In mammals, 
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the TLR family comprises more than 12 members (1). Although 
TLR1–TLR9 are conserved between humans and mice, TLR10 
is not functional in mice because of a retrovirus insertion, and 
TLR11, TLR12, and TLR13 are lost in the human genome (5). 
Surface TLRs such as TLR1, TLR2, TLR4, TLR5, TLR6, and 
TLR11 mainly recognize microbial membrane components 
including lipids, lipoproteins, and flagella. TLR3, TLR7, TLR8, 
and TLR9 are preferentially expressed in intracellular vesicles of 
the endoplasmic reticulum (ER), endosomes, and lysosomes and 
recognize both microbial and viral nucleic acid motifs [double-
stranded RNA, single-stranded RNA (ssRNA), and CpG-DNA 
are recognized by TLR3, TLR7/8, and TLR9, respectively] (6). 
TLRs responsible for sensing nucleic acids are expressed in 
various cell types, including dendritic cells (DCs), macrophages, 
and B cells (7). Microbial nucleic acids are an important class 
of PAMPs and self/non-self recognition is based on differ-
ent parameters, such as their sequence, structure, molecular 
modifications, and localization (mislocalized self nucleic acids 
such as extranuclear DNA or extracellular RNA are recognized 
as damage-associated molecular patterns) (8). There are recent 
reports on the properties of nucleic acid recognition for viral 
RNA and bacterial DNA (9, 10); however, little is known about 
the immunogenicity of prokaryotic RNA. Moreover, the role of 
TLRs acting as bacterial RNA sensors is controversial. Initially, 
it was reported that bacteria from group B Streptococcus (GBS) 
potently induced type I IFN in conventional DCs (cDCs) by a 
mechanism that required TLR7, MyD88, and the transcrip-
tion factor IRF-1. These molecules colocalized with bacterial 
products in degradative vacuoles bearing lysosomal markers, 
linking lysosomal recognition of bacterial RNA with a robust 
IFN response (11). Further, Eberle et al. demonstrated that bac-
terial RNA is a potent trigger for type I IFN secretion in human 
peripheral blood mononuclear cells. The same study reported 
that murine plasmacytoid DCs from TLR7-deficient mice were 
unable to trigger an immune response against bacterial RNA 
(12). In addition, Love et  al. demonstrated that the induction 
of IFN-α and IFN-λ1 (a type III IFN) by Borrelia burgdorferi 
RNA or live spirochetes requires TLR7-dependent signaling and 
an enhanced IRF7 expression (13). The TLR-mediated sensing 
to bacterial RNA depends on the cellular type studied and the 
chosen model of infection and some studies reported cases in 
which TLRs are not essential. For instance, Deshmukh et  al. 
reported that the recognition of ssRNA from GBS and other 
Gram-positive bacteria by macrophages and monocytes depends 
on the adaptors MyD88 and UNC93B, but not TLRs (14). It was 
also demonstrated by Gratz et al. that in cDCs and macrophages 
stimulated with Streptococcus pyogenes RNA, type I IFN was 
induced in the absence of TLR3, TLR7, and TLR9 (15).
Brucella abortus is a facultative, intracellular Gram-negative 
bacterium that causes brucellosis, an important zoonotic infec-
tion that causes reproductive disease in domestic animals and 
chronic debilitating disease in humans (16, 17). Brucella infects 
and multiplies in various cell types, including macrophages, DCs, 
and non-phagocytic cells (18). The first line of defense against 
brucellosis includes phagocytosis by professional phagocytes 
(neutrophils, macrophages, and DCs), and natural killer (NK) 
cells, recognition of PAMPs by PRRs (e.g., TLRs), secretion of 
cytokines and chemokines, and activation of the complement 
system (19, 20). Signaling B. abortus infection via TLRs has 
been investigated by several groups including ours. These studies 
have highlighted the involvement of TLR2, TLR4, TLR6, and 
TLR9, as well as a dependence of MyD88 on immune responses 
against this bacterium (21–26). To evade immune surveillance, 
Brucella is devoid of conspicuous molecular determinants such 
as pili, fimbriae, and capsules, and it possess non-canonical 
surface molecules, such as lipopolysaccharide (LPS), ornithine-
containing lipids, lipoproteins, and flagella, structures that lack 
marked PAMP activities and hence are very weak inducers of 
innate immunity (27). However, there are still few reports in the 
literature related to the host innate immune response against 
Brucella-derived nucleic acids (24, 28–30). Moreover, the role of 
Brucella RNA during bacterial infections remains undeciphered. 
In this study, we focused on the stimulatory activity of B. abortus 
RNA, as well as the role of TLR3 and TLR7 in cell signaling 
pathways and host protection against infection.
MaTerials anD MeThODs
Bacteria
Brucella abortus smooth virulent strain S2308 was obtained 
from our laboratory collection. All work with Brucella, including 
animal experiments, was conducted in the biosafety cabinet or 
a primary containment device within a dedicated laboratory. 
Appropriate laboratory coats, gloves, and protective eyewear 
were provided to ensure the safety of personnel. All personnel 
working in the biosafety laboratory were trained and approved for 
entry by an individual knowledgeable in the biosafety practices. 
Frozen stocks were prepared with bacteria previously grown in 
Brucella broth liquid medium (BB) (Becton Dickinson, Franklin 
Lakes, NJ, USA) at 37°C at 180 rpm. The bacterial culture was 
centrifuged after 72 h of growth and the pellet was resuspended 
in saline solution plus 25% glycerol. Aliquots of these cultures 
were serially diluted, plated on BB agar 1.5%, and after incuba-
tion for 72  h at 37°C, bacterial numbers were determined by 
counting CFU.
Mice
TLR3, TLR7, or MyD88 KO mice were kindly provided by Dr. 
Shizuo Akira, Osaka University, Japan. Wild-type (WT) strain 
C57BL/6 mice were obtained from the Federal University of 
Minas Gerais (UFMG, Belo Horizonte, Brazil). Genetically defi-
cient and control mice were maintained at our facilities and used 
at 6–8 weeks of age. All animal experiments were preapproved by 
the Institutional Animal Care and Use Committee of the UFMG 
(CETEA no. 104/2011). Mice were housed in filter-top cages and 
provided with sterile water and food ad libitum.
generation of Bone Marrow-Derived Dcs
Bone marrow cells were obtained from femur and tibiae of KO 
and WT mice, and they were differentiated into DCs as previously 
described (26, 31, 32). Briefly, bone marrow cells were cultured 
in RPMI medium 1640 (Thermo Fisher Scientific, Waltham, 
MA, USA) containing 10% fetal bovine serum (FBS), 100 U/mL 
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penicillin, 100  µg/mL streptomycin, and 20  ng/mL murine 
recombinant granulocyte-macrophage colony-stimulating factor 
(GM-CSF). Petri dishes containing 1 × 107 cells were incubated at 
37°C in a 5% CO2 atmosphere. On day 3 of incubation, a further 
5 mL of fresh complete medium containing GM-CSF was added, 
and on days 5 and 7, the medium was replaced with fresh supple-
mented medium containing GM-CSF. On day 10, non-adherent 
cells (immature DCs) were harvested, seeded in 24-well plates 
(5 ×  105 cells/well), and then incubated at 37°C in a 5% CO2 
atmosphere until use.
isolation of B. abortus Total rna from 
Bacterial cell culture
Bacteria were cultured for 3  days at 37°C in 10  mL BB liquid 
medium, and the bacterial suspension was pelleted into 10 
eppendorfs. The supernatants were removed and each pellet 
was resuspended in 1  mL TRIzol® (Thermo Fisher Scientific, 
Waltham, MA, USA). The procedure of RNA isolation was per-
formed following instructions of the manufacturer. Briefly, each 
TRIzol-bacterial suspension was vortexed, then 0.2 mL chloro-
form was added and the mixture was centrifuged at 11,000 × g 
during 10  min at 4°C. The aqueous phase was transferred to 
another eppendorf and 0.5 mL ice-cold isopropanol was added. 
The mixture was incubated at room temperature for 10 min and 
then centrifuged at 11,000 × g during 15 min at 4°C. The super-
natant was discarded and the precipitate was washed with 1 mL 
ice-cold ethanol 75%, through centrifugation at 7,500 × g during 
10 min at 4°C. The pellet was air-dried and resuspended using 
50 µL nuclease-free water. Total RNA was quantified using the 
Nanodrop 2000 spectrophotometer (Nanodrop 2000; Thermo 
Scientific), treated with DNase I and/or RNases A/T1 (Thermo 
Scientific) and stored at −80°C until use.
In Vitro stimulation of Dcs
Stimulation of the DCs was performed by adding RPMI plus 10% 
FBS (0.5 mL/well) containing B. abortus [multiplicity of infection 
(MOI) 100:1], Escherichia coli LPS (1  µg/mL; Sigma-Aldrich), 
or B. abortus total RNA (2  µg/mL) complexed with DOTAP 
Liposomal Transfection Reagent (Sigma-Aldrich, St. Louis, MO, 
USA). Briefly, DOTAP was mixed with bacterial RNA (5:1 ratio) 
in 100  µL/well serum-free RPMI and incubated for 20  min at 
room temperature. Then, complexes were added to the cells in 
the presence of 12.5% FBS and cell cultures were incubated for 
24 h at 37°C in a 5% CO2 atmosphere. Culture supernatants were 
collected after 24 h of stimulation and kept at −80°C until use. 
To the remaining cells, it was added 0.350 mL/well of TRIzol® to 
further RNA isolation.
rna isolation from Dcs and Quantitative 
real-time Pcr
Reverse transcription of 1  µg from total RNA was performed 
using Illustra™ Ready-To-Go RT-PCR Beads (GE Healthcare, 
Little Chalfont, UK), following instructions of the manufacturer. 
Quantitative real-time PCR was conducted in a final volume of 
10 µL containing the following: SYBR® Green PCR Master Mix 
(Thermo Fisher Scientific, Waltham, MA, USA), oligo-dT cDNA 
as the PCR template, and 5 µM of primers. The PCR reaction was 
performed with StepOne Plus Real-Time PCR System (Thermo 
Fisher Scientific, Waltham, MA, USA), using the following 
cycling parameters: 60°C for 10 min, 95°C for 10 min, 40 cycles 
of 95°C for 15 s and 60°C for 1 min, and a dissociation stage of 
95°C for 15 s, 60°C for 1 min, 95°C for 15 s, and 60°C for 15 s. 
Primers were used to amplify a specific 100–120  bp fragment 
corresponding to specific gene targets as follows: IFN-β, forward 
(5′-AGCTCCAAGAAAGGACGAACAT-3′); IFN-β, reverse 
(5′-GCCCTGTAGGTGAGGTTGATCT-3′); β-actin, forward 
(5′-AGGTGTGCACCTTTTATTGGTCTCAA-3′); β-actin, 
reverse (5′-TGTATGAAGGTTTGGTCTCCCT-3′). All data are 
presented as relative expression units after normalization to the 
β-actin gene. PCR measurements were conducted in triplicate.
inhibition of MaPK/nF-κB signaling 
Pathways in Dcs
DCs were pretreated with vehicle (0.1% DMSO) or selective inhibi-
tors for ERK1/2 (U0126; 10, 50, and 100 µM), JNK (SP600125; 1, 
5, and 10 µM), p38 (SB203580; 5, 25, and 50 µM), and NF-κB 
(BAY1170-82; 10, 100, and 500  µM) (all from Cell Signaling 
Technology, Danvers, MA, USA) for 45 min. Subsequently, cells 
were stimulated with B. abortus S2308 strain (MOI 100:1) or with 
bacterial RNA (2 µg/mL) for 24 h, and harvested supernatants 
were used to measure cytokine production by ELISA.
Measurement of il-12, il-6, iP-10/
cXcl10, and TnF-α by elisa
Collected supernatants of stimulated DCs were frozen until they 
were assayed for determination of cytokine concentrations using 
Mouse DuoSet ELISA (R&D Systems), according to the manu-
facturer’s specifications.
confocal Microscopy
Dendritic cells were differentiated on 12 mm glass coverslips in 
24-well plates, as described before. Infection with the B. abortus 
was performed at a MOI of 100:1. After 24 h of infection, cells 
were washed twice with PBS and fixed in 4% paraformaldehyde, 
pH 7.4, at 37°C for 15 min. Once fixed, cells were incubated with 
the primary antibody rat anti-lysosomal-associated membrane 
protein 1 (LAMP-1) diluted 1:200 (Abcam, Cambridge, UK) 
and rabbit anti-TLR7 diluted 1:100 (Abcam, Cambridge, UK) 
in PBS 0.1% saponin overnight. Then, cells were washed three 
times with PBS 0.1% saponin and were incubated for 1.5  h at 
room temperature with an anti-rabbit secondary antibody 
conjugated to Alexa 546 (Invitrogen, Carlsbad, CA, USA) and 
with an anti-rat secondary antibody conjugated to Alexa 488 
(Abcam, Cambridge, UK), both diluted 1:1,000. The cells were 
washed twice with PBS 0.1% saponin and once with PBS then 
mounted with the mounting medium ProLong Gold with DAPI 
(Invitrogen, Carlsbad, CA, USA). Stained cells were examined by 
confocal microscopy (Nikon C2 confocal microscope) and image 
analysis was performed using ImageJ software version 1.47n.
enumeration of B. abortus from spleens
To count residual B. abortus CFU in the spleens of C57BL/6 WT, 
TLR3 KO, TLR7 KO, and MyD88 KO mice, five mice from each 
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group were examined at 1 and 3  weeks postinfection. Spleens 
were homogenized with 10 mL of saline solution. To enumerate 
viable bacteria, homogenized spleen samples were serially diluted 
10-fold with saline solution and plated on BB agar (Becton 
Dickinson, Franklin Lakes, NJ, USA). CFUs were counted after 
3 days of incubation at 37°C.
statistical analysis
All experiments were repeated at least three times with similar 
results and figures show data from one representative experiment. 
Graphs and data analysis were done using GraphPad Prism 5 
(GraphPad Software), using one-way ANOVA, two-way ANOVA 
(Bonferroni post  hoc test), or Student’s t-test (Tukey’s post  hoc 
test).
resUlTs
lack of Tlr7 affects Proinflammatory 
cytokine Production by Dcs activated 
with B. abortus or its rna
To determine whether TLR3 and TLR7 are required to induce 
proinflammatory cytokine production in DCs stimulated with 
B. abortus, cells from C57BL/6, TLR3 KO, TLR7 KO, and MyD88 
KO were cultured with B. abortus (MOI 100:1) and after 24  h 
the supernatants were tested for production of IL-12, IL-6, and 
TNF-α by ELISA. IL-12 was partially reduced in TLR7 KO cells 
but not in TLR3 KO DCs (Figure 1A). Additionally, secretion of 
IL-6 and TNF-α was unaffected by the absence of TLR3 and TLR7 
(Figures 1C,E). Furthermore, IL-12, IL-6, and TNF-α production 
were totally abrogated in MyD88 KO cells.
Next, we assessed the potential of B. abortus RNA as TLR3 
and/or TLR7 agonist to induce proinflammatory cytokines. DCs 
from C57BL/6, TLR3 KO, TLR7 KO, and MyD88 KO were stimu-
lated with purified B. abortus RNA and after 24 h the supernatants 
were tested for production of IL-12, IL-6, and TNF-α. B. abortus 
RNA was able to induce the production of IL-12 and IL-6 in WT 
cells (Figures 1B,D) but not TNF-α (data not shown). Further, 
IL-12 and IL-6 secretion were completely abrogated in TLR7 
and MyD88 KO cells when compared to the WT DCs. However, 
IL-6 secretion was only partially dependent on TLR3 KO cells 
(Figure 1D). These results suggest that, upon B. abortus infec-
tion, only the lack of TLR7 partially affected IL-12 production in 
DCs. On the other hand, TLR3 and TLR7 are required to induce 
a cytokine response in DCs stimulated with Brucella-purified 
RNA. Additionally, our results also indicated that bacterial RNA 
treatment with RNases A/T1 abolished IL-12 and IL-6 in DCs, 
indicating that no other possible contaminant would be respon-
sible for the cytokine production observed (Figures 1B,D).
erK1/2, JnK, and nF-κB but not p38 
signaling are involved in cytokine 
Production in Dcs stimulated with  
B. abortus or Bacterial rna
Since B. abortus or its purified RNA induce the production of 
proinflammatory cytokines in DCs, we evaluated the role of 
MAPK components and the NF-κB transcription factor during 
cell activation. DCs from WT mice were treated with selective 
inhibitors against ERK1/2 (U0126), p38 (SB203580), JNK 
(SP600125), and NF-κB (BAY1170-82) before stimulation with 
B. abortus or bacterial RNA. Harvested supernatants were used to 
assess IL-12, IL-6, and TNF-α production (Figure 2). Treatment 
of DCs with the ERK1/2 inhibitor before infection with B. abor-
tus reduced the production of all three cytokines, whereas the 
cytokine production was not significantly altered by inhibition 
of p38. Moreover, inhibition of JNK in DCs stimulated with 
B. abortus resulted in a decrease in IL-12 and IL-6 but not TNF-
α. It was also observed that IL-12, IL-6, and TNF-α production 
are reduced in infected cells treated with a selective inhibitor of 
NF-κB (Figures 2A,C,E).
We also assessed whether the pretreatment with MAPK/
NF-κB inhibitors would affect cytokine production in DCs 
stimulated with B. abortus RNA. Both ERK1/2 and JNK inhibi-
tors, as well as the NF-κB inhibitor, were able to reduce IL-6 
production in DCs stimulated with bacterial RNA (Figure 2D). 
As observed for live bacteria, p38 inhibitor did not reduce the 
production of any studied cytokine in the supernatant of these 
cells. Besides, IL-12 production was diminished only in super-
natants from DCs pretreated with JNK and NF-κB inhibitors 
(Figure 2B), which suggests that DCs infected with live bacteria 
may be exposed to other bacterial agonists that are recognized 
via ERK besides to JNK and NF-κB. Importantly, the reduction 
in cytokine production mediated by U0126, SP600125, and 
BAY1170-82 is not a consequence of toxicity caused by the 
inhibitors since treatment induces slight levels of cell death 
and only in high concentrations (Figure S1 in Supplementary 
Material). Once again, TNF-α production was not detected in 
DCs stimulated with B. abortus RNA, pretreated or not with 
the inhibitors previously mentioned (data not shown). All 
together, these results indicate that MAPK and NF-κB activation 
participates in proinflammatory cytokine production in DCs 
stimulated with B. abortus or its RNA.
Tlr7 and laMP-1 are colocalized in  
B. abortus-infected Dcs
Results shown in Figure 1 suggest that IL-12 production in DCs 
stimulated with B. abortus or its purified RNA depends on the 
signaling via TLR7. Upon entry into mammalian cells, B. abortus 
resides within a membrane-bound, ER-derived compartment, 
the Brucella-containing vacuole (BCV). Before reaching the 
ER, the bacteria ensure its intracellular survival by inhibit-
ing fusion of the intermediate BCV with late endosomes and 
lysosomes, in which we observe the presence of LAMP-1 (33). 
Therefore, to gain insight into the role of TLR7 in the response 
to B. abortus infection, we performed confocal microscopy in 
infected DCs, labeling cells with anti-TLR7 and anti-LAMP-1 
antibody, and visualizing by confocal microscopy. Our results 
suggest that upon infection of WT DCs with B. abortus, TLR7 
traffics to LAMP-1+ endosomes, spreading throughout the 
cells (Figure 3). Indeed, colocalization of TLR7 and Brucella in 
LAMP-1+ compartments could facilitate sensing of RNA released 
from bacteria and subsequent cytokine production. As expected, 
there was no TLR7 staining in TLR7 KO DCs. Further, TLR7 
FigUre 1 | secretion of proinflammatory cytokines in dendritic cells (Dcs) after stimulation with Brucella abortus or bacterial rna. DCs were 
stimulated with B. abortus strain S2308 (MOI 100:1) or lipopolysaccharide (LPS) (1 µg/mL) (a,c,e), or bacterial RNA (2 μg/mL) (B,D). Supernatants were harvested 
after 24 h after stimulation and cytokine secretion was determined by ELISA. Significant differences in relation to wild-type mice are denoted (for ***p < 0.001, 
two-way ANOVA test).
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KO DCs showed phenotypically distinct clustered, membrane-
bound LAMP-1+ BCV-like structures, when compared to WT 
DCs. All together, these results suggest that TLR7 is involved in 
a B. abortus-induced signaling pathway, leading to a proinflam-
matory cytokine production.
Tlr3 and Tlr7 are required for Type i 
iFn expression and iP-10/cXcl10 
secretion in Dcs stimulated with  
B. abortus rna
It is known that upon TLR3 and TLR7 recognition of nucleic 
acids released into endosomes after virus or bacteria internaliza-
tion or lysis results in type I IFN production, particularly IFN-β 
(34, 35). Therefore, we decided to investigate the levels of IFN-β 
expression and IP-10/CXCL10 production, a surrogate marker 
of type I IFN (36, 37), in TLR3 and TLR7 KO DCs activated with 
B. abortus or its purified RNA. We have observed no significant 
reduction on IFN-β expression and IP-10/CXCL10 production 
in TLR3 and TLR7 KO cells infected with B. abortus when 
compared to the WT (Figures 4A,C). Bacterial RNA was able 
to induce the expression of IFN-β and IP-10/CXCL10 produc-
tion in WT DCs; however, the levels of these cytokines were 
diminished in TLR3 KO and TLR7 KO cells (Figures  4B,D). 
IFN-β expression and IP-10/CXCL10 production were only 
partially reduced in MyD88 KO cells because the IFN-responsive 
gene expression can also be activated via TLR3–TRIF pathway 
(38, 39). However, when MyD88 KO cells were activated with 
bacterial RNA a dramatic reduction on cytokine levels were 
observed. The previous treatment of RNA with RNases abolished 
the differences between KO and WT cells.
Tlr3 and Tlr7 are not required to 
control B. abortus infection In Vivo
Results obtained from in  vitro studies indicate that TLR3 and 
TLR7 play a role in cytokine production and type I IFN expression 
upon stimulation with B. abortus RNA but are dispensable for the 
induction of an immune response against live bacteria. Therefore, 
to test the role of these receptors in host defense against Brucella 
infection in vivo, C57BL/6 WT, TLR3 KO, TLR7 KO, and MyD88 
KO mice to test the role of these receptors in host defense against 
Brucella infection in  vivo. Mice were infected intraperitoneally 
with 106 CFU B. abortus and the number of bacteria in the spleen 
was quantified. TLR3 and TLR7 KO mice were able to effectively 
control Brucella infection as the WT animals at 1 and 3 weeks 
postinfection (Figure 5). MyD88 KO were used as a control group 
and showed the highest CFU numbers in the spleen compared 
to other strains tested here, indicating their susceptibility to 
infection.
FigUre 2 | MaPK/nF-κB signaling pathways involved on cytokine production in dendritic cells (Dcs) after stimulation with Brucella abortus or 
bacterial rna. DCs from C57BL/6 mice were pretreated for 45 min with increasing concentrations (in micromolars) of U0126, SB203580, SP600125, and 
BAY11-7082 (ERK1/2, p38, JNK, and NF-κB inhibitors, respectively) or vehicle, as indicated, and then stimulated with B. abortus (MOI 100:1) (a,c,e) or bacterial 
RNA (2 µg/mL) (B,D). Supernatants were harvested after 24 h after stimulation and cytokine secretion was determined by ELISA. Abbreviations: NI, non-infected; C, 
Control, DOTAP only;, RNA, DOTAP + RNA. Significant differences in relation to vehicle treatment are denoted (for *p < 0.05, **p < 0.01, and ***p < 0.001, two-way 
ANOVA test).
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FigUre 3 | Dendritic cells (Dcs) activated by Brucella abortus 
promote Tlr7 colocalization with lysosomal-associated membrane 
protein 1 (laMP-1)-positive compartments. DCs were stimulated with  
B. abortus (MOI 100:1) for 24 h. Subsequently, macrophages were fixed and 
stained to detect host cell and bacterial DNA (blue), TLR7 (red), and LAMP-1 
(green) by confocal microscopy. The colocalization between TLR7 and 
LAMP-1 is highlighted in inserts. NI, non-infected.
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DiscUssiOn
Here, we provided evidence that B. abortus RNA function as 
an immunostimulatory PAMP that induces the production 
of proinflammatory cytokines in bone marrow-derived DCs. 
DCs stimulated with bacterial RNA produced significant 
amounts of IL-12 and IL-6 (Figures  1B,D), and this produc-
tion is decreased when cells are pretreated with MAPK/NF-κB 
inhibitors (Figures  2B,D). Moreover, B. abortus RNA induces 
IFN-β expression (Figure  4B) and IP-10/CXCL10 produc-
tion (Figure 4D). On the other hand, although we observed a 
robust secretion of TNF-α in DCs stimulated with B. abortus 
(Figure 1E), there was no detectable TNF-α production in RNA-
stimulated cells (data not shown). Results reported by Eberle 
et  al. indicated that TNF-α secretion in murine DCs induced 
by bacterial RNA is independent of endosomal maturation and 
consequently independent of endosomal nucleic acid-sensing 
TLRs (12). Furthermore, the transfection of DCs with RNA 
complexed to DOTAP, a cationic lipid that mimics the chemical 
and physical attributes of biological lipids (40), allows direct 
delivery of RNA to endosomes, avoiding a possible nucleic acid 
sensing by cytosolic sensors, for example, members of retinoic 
acid-inducible gene I (RIG-I)-like receptors family: RIG-I, 
melanoma differentiation factor 5 (MDA5), and laboratory of 
genetics and physiology 2 (LGP2) (38).
Our data reported here also reveal that B. abortus RNA 
is recognized in a TLR3- and TLR7-dependent manner by 
DCs. However, the involvement of these two receptors is only 
noticed upon stimulation with purified RNA complexed to 
DOTAP and not upon infection with live bacteria (Figures 1 
and 4). Alternatively, the immune responses against 
B. abortus infection could be triggered by major agonists such 
as DNA, lipoproteins, or LPS, and probably such stimuli are 
more efficient in activating proinflammatory cytokine secre-
tion and type I IFN expression than bacterial RNA. A recent 
review published by our group describes B. abortus DNA 
as a major agonist to activate innate responses against this 
bacterium, and this activation is mediated by the endosomal 
TLR9 as well as cytosolic molecules such as AIM2 and STING 
(30). Moreover, endosomal TLRs may interact with each 
other, resulting in a unidirectional and hierarchical inhibi-
tion. In a work performed by Wang and colleagues in 2006, 
it was demonstrated a cooperative interaction among TLR7, 
TLR8, and TLR9, in HEK293 cells transfected with human 
or murine TLRs in a paired combination (39). In this study, 
the results indicated that TLR8 inhibits TLR7 and TLR9, 
and TLR9 inhibits TLR7 but TLR7 does not inhibit TLR8 
neither TLR9. Furthermore, in mice, it is possible that the 
inflammatory response triggered upon TLR7 activation may 
be modulated by TLR8 in all DC subsets. We cannot rule out 
the possibility that B. abortus RNA is sensed by other PRRs 
in a MyD88-dependent pathway, since both IFN-β expres-
sion and IP-10/CXCL10 secretion are abrogated in MyD88 
KO DCs (Figures 4B,D). TLR13, a PRR involved in sensing 
a specific sequence from bacterial 23S rRNA, is present in 
mice but not in humans (41, 42). It is possible that TLR13 
may play a role in B. abortus RNA sensing, but this hypothesis 
needs further investigation. The assumptions aforementioned 
could also explain the results obtained in Figure 5, in which 
we compared bacterial clearance in vivo in WT, TLR3 KO, and 
TLR7 KO mice and we observed no significant differences 
among these studied groups. Similar findings were previously 
described by Oliveira and coworkers, where the macrophages 
derived from NOD1, NOD2, and RIP2 KO mice showed an 
altered IL-12 and TNF-α secretion but no differences were 
observed among these groups in vivo (43).
Brucella abortus has developed sophisticated molecular 
strategies to ensure its survival inside host cells by forming 
BCVs, which traffics from the endocytic vesicle to the ER, where 
the bacterium proliferates (44). BCV maturation is evidenced 
by the exclusion of LAMP-1, possibly by recycling LAMP-1+ 
membranes while interacting with the ER (45). Results shown in 
the Figure 3 demonstrate that, after 24 h of infection, B. abortus 
colocalized with TLR7 in BCVs that retain LAMP-1 labeling. 
However, it is important to highlight that literature on BCV 
maturation is based on studies using macrophages, and BCVs 
from infected DCs could present alterations on their membrane 
constitution. In addition, it is possible that in infected DCs 
ER-localized Brucella could hold membrane rearrangements 
dependent upon a subset of autophagy-associated proteins, 
producing vacuolar LAMP-1+ compartments that are pheno-
typically distinct from ER-derived BCVs, so called autophagic 
Brucella-containing vacuoles (44).
In summary, our findings shown here suggest that 
B. abortus RNA is an important immunostimulatory nucleic 
acid, and bacterial RNA-initiated TLR3 and TLR7 signaling 
contributes to cytokine response and type I IFN expression 
in murine DCs. To the best of our knowledge, this study 
reports for the first time the involvement of RNA sensing 
TLRs on innate immune responses against Brucella infection 
FigUre 5 | The control of Brucella abortus infection in vivo in mice deficient for Tlr3, Tlr7, and for the adaptor molecule MyD88. Residual B. abortus 
CFU in the spleen of wild-type (WT) and KO mice were determined after 1 (a) and 3 (B) weeks postinfection. Significant differences in relation to WT mice are 
denoted (***p < 0.001, Student’s t-test).
FigUre 4 | Type i iFn expression and iP-10/cXcl10 secretion in dendritic cells (Dcs) stimulated with Brucella abortus or bacterial rna. DCs were 
stimulated with B. abortus strain S2308 (MOI 100:1) (a,c) or bacterial RNA (2 µg/mL) (B,D) for 24 h. Total RNA was isolated from these cells, first-strand cDNA 
synthesis was performed as indicated in Section “Materials and Methods” and subjected to qPCR analysis. Supernatants were analyzed by ELISA. Significant 
differences related to wild-type mice are denoted (***p < 0.001, two-way ANOVA test).
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and highlights the importance of nucleic acid sensing during 
bacterial diseases.
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